| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |